References
- Taylor MA, Fink M. Catatonia in psychiatric classification: a home of its own. Am J Psychiatry 2003; 160: 1233–1241
- Taylor, MA. Clinical examination. In:. S Caroff, Mann, S, Francis, A, Fricchione, G. Catatonia: from psychopathology to neurobiology. Washington, DC: American Psychiatric Press, 2004:45–52.
- Fink M, Taylor MA. Catatonia: a clinician's guide to diagnosis and treatment. Cambridge University Press, Cambridge 2003
- Losonczy MF, Song IS, Mohs RC, et al. Correlates of lateral ventricular size in chronic schizophrenia, I behavioral and treatment response measures. Am J Psychiatry 1986; 143: 976–981
- Steinman TI, Yager HM. Catatonia in uremia. Ann Intern Med 1978; 89: 74–75
- Steinberg P. Adrenal carcinoma and hypertension presenting with catatonic stupor. Aust N Z J Psychiatry 1996; 30: 146–149
- Woods SW. Catatonia in a patient with subdural hematomas. Am J Psychiatry 1980; 137: 983–984
- Pfister HW, Preac-Mursic V, Wilske B, et al. Catatonic syndrome in acute severe encephalitis due to Borrelia burgdorferi infection. Neurology 1993; 43: 433–435
- Gelenberg AJ, Mandel MR. Catatonic reactions to high potency neuroleptic drugs. Arch Gen Psychiatry 1977; 34: 947–950
- White DAC, Robins AH. Catatonia: harbinger of the neuroleptic malignant syndrome. Br J Psychiatry 1991; 158: 419–421
- Taylor MA. Catatonia: a review of a behavioral neurologic syndrome. Neuropsych Neuropsych Behav Neurol 1990; 3: 48–72
- American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn. Washington, DC: American Psychiatric Press, 1999.
- Ungvari GS, Chiu HF, Lau BS, Tang WK. Lorazepam for chronic catatonia: a randomized, double-blind, placebo controlled cross-over study. Psychopharmacology (Berl) 1999; 142: 393–398
- Rosebush PI, Hildebrand AM, Furlong BG, Mazurek MF. Catatonic syndrome in a general psychiatric population: frequency, clinical presentation, and response to Lorazepam. J Clin Psychiatry 1990; 51: 357–362
- Lohr JB, Wisenewski AA. Movement disorders: a neuropsychiatric approach. Guilford Press, New York 1987
- Bush G, Fink M, Petrides G, Dowling F, Francis A. Catatonia I. Rating scale and standard examination. Acta Psychiatr Scand 1996; 93: 129–136
- Northoff G. What catatonia can tell us about “top-down modulation”: a neuropsychiatric hypothesis. Behav Brain Sci 2002; 25: 555–577
- Lee JW, Schwartz D, Hallmayer J. Catatonia in a psychiatric intensive care facility: incidence and response to benzodiazepines. Ann Clin Psychiatry 2000; 12: 89–96
- Gaind GS, Rosebush PI, Mazurek MF. Lorazepam treatment of acute and chronic catatonia in two mentally retarded brothers. J Clin Psychiatry 1994; 55: 20–23
- Ripley TL, Millson RC. Psychogenic catatonia treated with lorazepam. Am J Psychiatry 1988; 145: 764–765
- Valevski A, Loebl T, Keren T, Bodinger L, Weizman A. Response of catatonia to risperidone: two case reports. Clin Neuropharmacol 2001; 24: 228–231
- Numata S, Kato O, Misawa H, Kanai T, Kasahara T, Ohmori T. Treatment of catatonia with olanzapine. German J Psychiatry 2002; 5: 115–116
- Rommel O, Tegenthoff M, Widdig W, Braunig P, Malin JP. Organic catatonia following frontal lobe injury: response to clozapine. J Neuropsychiatry Clin Neurosci 1998; 10: 237–238